Brady Lee Stein

  • 1001 Citations
20072022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Hematology

Training Experience

2006Residency, Johns Hopkins Hospital
2010Fellowship, Johns Hopkins Hospital

Education/Academic qualification

MD, Emory University

… → 2003

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Interferons Medicine & Life Sciences
Thrombocytosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2011 2022

Research Output 2007 2019

Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?

Mina, A. A. & Stein, B. L., Jun 15 2019, In : Current Hematologic Malignancy Reports. 14, 3, p. 137-144 8 p.

Research output: Contribution to journalReview article

Polycythemia Vera
Primary Myelofibrosis
Essential Thrombocythemia
Thrombocytosis
Neoplasms
Hydroxyurea
Second Primary Neoplasms
Pipobroman
Chlorambucil
Neoplasms

ASXL1 mutations in idiopathic cytopenias: determined significance?

Galvez, C. & Stein, B. L., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Mutation
1 Citation (Scopus)

Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States

Grunwald, M. R., Stein, B. L., Boccia, R. V., Oh, S. T., Paranagama, D., Parasuraman, S., Colucci, P. & Mesa, R., Dec 1 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 12, p. 788-795.e2

Research output: Contribution to journalArticle

Polycythemia Vera
Observational Studies
Prospective Studies
Demography
Patient Acceptance of Health Care

Do all patients with polycythemia vera or essential thrombocythemia need cytoreduction?

Sankar, K. & Stein, B. L., Dec 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 12, p. 1539-1545 7 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Polycythemia Vera
Blood Vessels
Primary Myelofibrosis
Thrombosis